Home › Funds › BIT Capital GmbH › RARE

BIT Capital GmbH position in RARE

ULTRAGENYX PHARMACEUTICAL IN · Health Care

BIT Capital GmbH reported holding 91,391 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN) in its Q2 2026 13F filing — a position valued at US$3.1M, representing 0.14% of its reported portfolio and ranking #45 among its reported holdings. BIT Capital GmbH has disclosed RARE holdings in 9 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)91.39K sh
Reported value held$3.05M
Portfolio Weight0.14%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BIT Capital GmbH's RARE position evolved

BIT Capital GmbH first disclosed a stake in RARE in Q4 2023 at 1,555 shares (US$74K). The position peaked in Q2 2026 at 91,391 shares, worth US$3.1M. Across 9 filings, BIT Capital GmbH increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 91,391 shares valued at US$3.1M — an increase of 73,391 shares quarter over quarter.. Notable position changes include a 2537% increase in Q1 2024 (shares fell 12% over the following quarter), a 91% trim in Q2 2025 (shares fell 17% over the following quarter), a 408% increase in Q2 2026 (shares fell 55% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 1.55K $74.36K New
Q1 2024 41.00K $1.91M Add
Q2 2024 32.26K $1.33M Reduce
Q3 2024 29.87K $1.66M Reduce
Q4 2024 29.87K $1.26M Hold
Q1 2025 21.66K $784.13K Reduce
Q2 2025 2.06K $74.72K Reduce
Q1 2026 18.00K $377.10K New
Q2 2026 91.39K $3.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RARE and 13F data

RARE (ULTRAGENYX PHARMACEUTICAL IN) is a Health Care company. 27 other funds we track also report a position in RARE — the largest reported positions include RTW INVESTMENTS, LP (US$260.3M), SANDS CAPITAL MANAGEMENT, LLC (US$105.5M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RARE

All RARE fund holders →

FAQ

How long has BIT Capital GmbH held RARE?

BIT Capital GmbH has disclosed RARE holdings in 9 of the last 11 reported quarters, going back to Q4 2023.

What is BIT Capital GmbH's current position in RARE?

As of Q2 2026, BIT Capital GmbH holds 91.39K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $3.05M, representing 0.14% of its reported portfolio and ranking #45.

Has BIT Capital GmbH been buying or selling RARE?

In the latest 13F filing (Q2 2026), BIT Capital GmbH increased its position in RARE. The position peaked in Q2 2026 at 91.39K shares.

Which other funds hold RARE?

Other major institutional holders of RARE include RTW INVESTMENTS, LP, SANDS CAPITAL MANAGEMENT, LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.